Login / Signup
Udit Chaube
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 6
Top Topics
Cell Proliferation
Double Blind
Helicobacter Pylori
Clinical Trial
Top Venues
Future medicinal chemistry
3 Biotech
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Udit Chaube
,
Rajdeep Dey
,
Suman Shaw
,
Bhumika D Patel
,
Hardik G Bhatt
Tetrahydroquinoline: an efficient scaffold as mTOR inhibitor for the treatment of lung cancer.
Future medicinal chemistry
14 (23) (2022)
Udit Chaube
,
Rajdeep Dey
,
Suman Shaw
,
Bhumika D Patel
,
Hardik G Bhatt
Tetrahydroquinoline: an efficient scaffold as mTOR inhibitor for the treatment of lung cancer.
Future medicinal chemistry
(2022)
Udit Chaube
,
Bhumika D Patel
,
Hardik G Bhatt
A hypothesis on designing strategy of effective RdRp inhibitors for the treatment of SARS-CoV-2.
3 Biotech
13 (1) (2022)
Udit Chaube
,
Rajdeep Dey
,
Suman Shaw
,
Bhumika D Patel
,
Hardik G Bhatt
Tetrahydroquinoline: an efficient scaffold as mTOR inhibitor for the treatment of lung cancer.
Future medicinal chemistry
14 (23) (2022)
Udit Chaube
,
Bhumika D Patel
,
Hardik G Bhatt
A hypothesis on designing strategy of effective RdRp inhibitors for the treatment of SARS-CoV-2.
3 Biotech
13 (1) (2022)
Udit Chaube
,
Rajdeep Dey
,
Suman Shaw
,
Bhumika D Patel
,
Hardik G Bhatt
Tetrahydroquinoline: an efficient scaffold as mTOR inhibitor for the treatment of lung cancer.
Future medicinal chemistry
14 (23) (2022)